The EHC released the first edition of the 2025 EHC Public Policy Review (PPR) of relevant EU legislation.

The key highlights in the latest edition include:

• As the one of the top priorities for EU health policy, the European Commission is expected to propose the EU Critical Medicines Act is a legislative initiative aimed at addressing the European Union’s vulnerability to disruptions in the supply of critical medicines.
• The European Health Technology Assessment (HTA) Regulation 2021/2282 represents a fundamental shift in how medical technologies are evaluated across the European Union. Implemented in January 2025, this groundbreaking legislation establishes a permanent framework for joint assessments, marking a significant advancement in European healthcare policy harmonization.
• The European Commission’s health agenda for 2024-2029 will likely aim to strengthen healthcare systems across the EU, ensuring they are resilient, accessible, and capable of addressing future health crises. Key priorities include enhancing crisis preparedness and management, particularly in response to pandemics and cross-border health threats, while improving access to affordable medicines, vaccines, and medical equipment.

This publication is entirely developed by the EHC to inform its National Member Organisations (NMOs) about the rapidly changing landscape of health policy and legislative developments which have a direct impact on the bleeding disorders community. Initially sent to EHC members in the form of a quarterly policy review, this informational product has recently been transformed into a periodic report available to readers on the EHC Academy.